Review



staining set diff-quik  (Medion Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Medion Diagnostics staining set diff-quik
    Staining Set Diff Quik, supplied by Medion Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/diff+quik/pm40112898-153-9-10
    Average 90 stars, based on 1 article reviews
    staining set diff-quik - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Staining:

    Article Title: PEGylation of Recombinant Human Deoxyribonuclease I Provides a Long‐Acting Version of the Mucolytic for Patients with Cystic Fibrosis
    Article Snippet: Inhalation of recombinant human deoxyribonuclease I (rhDNase) is a gold-standard therapy in the management of cystic fibrosis (CF).. Yet, the rapid elimination of the mucolytic from the lungs requires its daily administration and rhDNase contributes to the high therapy burden of patients.. Here, a long-acting version of rhDNase that is delivered once weekly instead of once daily is presented.

    Article Title: Impact of administration route and PEGylation on alpha-1 antitrypsin augmentation therapy.
    Article Snippet: Patients suffering from emphysema associated with alpha-1 antitrypsin (AAT) deficiency can benefit from augmentation therapy.. AAT is administered to the patient once a week via intravenous infusion by a healthcare professional.. However, only 2 % of the AAT dose reaches the lungs following intravenous infusion.

    Diff-Quik:

    Article Title: PEGylation of Recombinant Human Deoxyribonuclease I Provides a Long‐Acting Version of the Mucolytic for Patients with Cystic Fibrosis
    Article Snippet: Inhalation of recombinant human deoxyribonuclease I (rhDNase) is a gold-standard therapy in the management of cystic fibrosis (CF).. Yet, the rapid elimination of the mucolytic from the lungs requires its daily administration and rhDNase contributes to the high therapy burden of patients.. Here, a long-acting version of rhDNase that is delivered once weekly instead of once daily is presented.

    Article Title: Impact of administration route and PEGylation on alpha-1 antitrypsin augmentation therapy.
    Article Snippet: Patients suffering from emphysema associated with alpha-1 antitrypsin (AAT) deficiency can benefit from augmentation therapy.. AAT is administered to the patient once a week via intravenous infusion by a healthcare professional.. However, only 2 % of the AAT dose reaches the lungs following intravenous infusion.



    Similar Products

    diff quik stain set  (Dade Behring)
    86
    Dade Behring diff quik stain set
    Diff Quik Stain Set, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/diff+quick/pmc12635137-130-10-13
    Average 86 stars, based on 1 article reviews
    diff quik stain set - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    diff-quik ® fixative/stain set  (Dade Behring)
    90
    Dade Behring diff-quik ® fixative/stain set
    Diff Quik ® Fixative/Stain Set, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/diff+quik+stain+set/pmc12139374-64-20-24
    Average 90 stars, based on 1 article reviews
    diff-quik ® fixative/stain set - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    diff-quik® fixative/stain set  (Dade Behring)
    90
    Dade Behring diff-quik® fixative/stain set
    Diff Quik® Fixative/Stain Set, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/diff+quik+stain+set/pm40468407-55-19-22
    Average 90 stars, based on 1 article reviews
    diff-quik® fixative/stain set - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    diff-quik stain set  (Siemens Healthineers)
    90
    Siemens Healthineers diff-quik stain set
    Diff Quik Stain Set, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/diff+quik+stain+set/pmc11900935-71-19-22
    Average 90 stars, based on 1 article reviews
    diff-quik stain set - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    staining set diff-quik  (Medion Diagnostics)
    90
    Medion Diagnostics staining set diff-quik
    Staining Set Diff Quik, supplied by Medion Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/diff+quik/pm40112898-153-9-10
    Average 90 stars, based on 1 article reviews
    staining set diff-quik - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    diff-quik staining set medion diagnostics  (Medion Diagnostics)
    90
    Medion Diagnostics diff-quik staining set medion diagnostics
    Diff Quik Staining Set Medion Diagnostics, supplied by Medion Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/diff+quik+staining+set+medion+diagnostics/pmc11496330-58-12-15
    Average 90 stars, based on 1 article reviews
    diff-quik staining set medion diagnostics - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    diff quik staining set  (Thermo Fisher)
    90
    Thermo Fisher diff quik staining set
    Anti-asthmatic effect of oleic acid according to BALF and serum IgE analysis and histopathological observation. The populations of (A) WBCs and (B) eosinophils (Eos) in the bronchoalveolar lavage fluid (BALF) were elevated due to OVA exposure and subsequently reduced by oleic acid treatment. Notably, oleic acid reduced the number of white blood cells and eosinophils in a concentration-dependent manner (n = 4). (C) Observation of inflammatory cells in BALF through Diff <t>Quik</t> <t>staining</t> showed a dose-dependent decrease with oleic acid treatment. Scale bar, 100 μm; magnification, 400×. (D) Serum IgE levels, which were elevated in the OVA-induced group, decreased in a dose-dependent manner with oleic acid treatment at various concentrations (n = 8). (E) Lung morphology, characterized by hypersecretion of mucus, proliferation of epithelial cells, and infiltration of inflammatory cells around the bronchoalveolar ducts and blood vessels, which were altered due to OVA, improved with oleic acid treatment in a dose-dependent manner. Scale bar, 100 μm; magnification, × 200. (F) Bronchoalveolar mucus secretion induced by OVA was reduced by treatment with varying concentrations of oleic acid (in a dose-dependent manner). Scale bar, 100 μm; magnification, × 200. a, CON; b, OVA; c, 1 mg/kg DEX; d, 50 mg/kg oleic acid; e, 125 mg/kg oleic acid; f, 250 mg/kg oleic acid. The results are expressed as the mean ± standard deviation. * p < 0.05 vs. CON; ** p < 0.001 vs. CON; $ p < 0.05 vs. OVA; $$ p < 0.001 vs. OVA; # p < 0.05 vs. 1 mg/kg DEX; ## p < 0.001 vs. 1 mg/kg DEX; @ p < 0.05 vs. 50 mg/kg oleic acid; @@ p < 0.001 vs. 50 mg/kg oleic acid; & p < 0.05 vs. 125 mg/kg oleic acid.
    Diff Quik Staining Set, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/pmc11484255-105-26-30
    Average 90 stars, based on 1 article reviews
    diff quik staining set - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    wright-giemsa combination stain ral diff-quik stain set  (Siemens Healthineers)
    90
    Siemens Healthineers wright-giemsa combination stain ral diff-quik stain set
    Anti-asthmatic effect of oleic acid according to BALF and serum IgE analysis and histopathological observation. The populations of (A) WBCs and (B) eosinophils (Eos) in the bronchoalveolar lavage fluid (BALF) were elevated due to OVA exposure and subsequently reduced by oleic acid treatment. Notably, oleic acid reduced the number of white blood cells and eosinophils in a concentration-dependent manner (n = 4). (C) Observation of inflammatory cells in BALF through Diff <t>Quik</t> <t>staining</t> showed a dose-dependent decrease with oleic acid treatment. Scale bar, 100 μm; magnification, 400×. (D) Serum IgE levels, which were elevated in the OVA-induced group, decreased in a dose-dependent manner with oleic acid treatment at various concentrations (n = 8). (E) Lung morphology, characterized by hypersecretion of mucus, proliferation of epithelial cells, and infiltration of inflammatory cells around the bronchoalveolar ducts and blood vessels, which were altered due to OVA, improved with oleic acid treatment in a dose-dependent manner. Scale bar, 100 μm; magnification, × 200. (F) Bronchoalveolar mucus secretion induced by OVA was reduced by treatment with varying concentrations of oleic acid (in a dose-dependent manner). Scale bar, 100 μm; magnification, × 200. a, CON; b, OVA; c, 1 mg/kg DEX; d, 50 mg/kg oleic acid; e, 125 mg/kg oleic acid; f, 250 mg/kg oleic acid. The results are expressed as the mean ± standard deviation. * p < 0.05 vs. CON; ** p < 0.001 vs. CON; $ p < 0.05 vs. OVA; $$ p < 0.001 vs. OVA; # p < 0.05 vs. 1 mg/kg DEX; ## p < 0.001 vs. 1 mg/kg DEX; @ p < 0.05 vs. 50 mg/kg oleic acid; @@ p < 0.001 vs. 50 mg/kg oleic acid; & p < 0.05 vs. 125 mg/kg oleic acid.
    Wright Giemsa Combination Stain Ral Diff Quik Stain Set, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+set+diff-quik/wright+giemsa+combination+stain+ral+diff+quik+stain+set/pm39219026-75-20-30
    Average 90 stars, based on 1 article reviews
    wright-giemsa combination stain ral diff-quik stain set - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Anti-asthmatic effect of oleic acid according to BALF and serum IgE analysis and histopathological observation. The populations of (A) WBCs and (B) eosinophils (Eos) in the bronchoalveolar lavage fluid (BALF) were elevated due to OVA exposure and subsequently reduced by oleic acid treatment. Notably, oleic acid reduced the number of white blood cells and eosinophils in a concentration-dependent manner (n = 4). (C) Observation of inflammatory cells in BALF through Diff Quik staining showed a dose-dependent decrease with oleic acid treatment. Scale bar, 100 μm; magnification, 400×. (D) Serum IgE levels, which were elevated in the OVA-induced group, decreased in a dose-dependent manner with oleic acid treatment at various concentrations (n = 8). (E) Lung morphology, characterized by hypersecretion of mucus, proliferation of epithelial cells, and infiltration of inflammatory cells around the bronchoalveolar ducts and blood vessels, which were altered due to OVA, improved with oleic acid treatment in a dose-dependent manner. Scale bar, 100 μm; magnification, × 200. (F) Bronchoalveolar mucus secretion induced by OVA was reduced by treatment with varying concentrations of oleic acid (in a dose-dependent manner). Scale bar, 100 μm; magnification, × 200. a, CON; b, OVA; c, 1 mg/kg DEX; d, 50 mg/kg oleic acid; e, 125 mg/kg oleic acid; f, 250 mg/kg oleic acid. The results are expressed as the mean ± standard deviation. * p < 0.05 vs. CON; ** p < 0.001 vs. CON; $ p < 0.05 vs. OVA; $$ p < 0.001 vs. OVA; # p < 0.05 vs. 1 mg/kg DEX; ## p < 0.001 vs. 1 mg/kg DEX; @ p < 0.05 vs. 50 mg/kg oleic acid; @@ p < 0.001 vs. 50 mg/kg oleic acid; & p < 0.05 vs. 125 mg/kg oleic acid.

    Journal: Frontiers in Immunology

    Article Title: Oleic acid attenuates asthma pathogenesis via Th1/Th2 immune cell modulation, TLR3/4-NF-κB-related inflammation suppression, and intrinsic apoptotic pathway induction

    doi: 10.3389/fimmu.2024.1429591

    Figure Lengend Snippet: Anti-asthmatic effect of oleic acid according to BALF and serum IgE analysis and histopathological observation. The populations of (A) WBCs and (B) eosinophils (Eos) in the bronchoalveolar lavage fluid (BALF) were elevated due to OVA exposure and subsequently reduced by oleic acid treatment. Notably, oleic acid reduced the number of white blood cells and eosinophils in a concentration-dependent manner (n = 4). (C) Observation of inflammatory cells in BALF through Diff Quik staining showed a dose-dependent decrease with oleic acid treatment. Scale bar, 100 μm; magnification, 400×. (D) Serum IgE levels, which were elevated in the OVA-induced group, decreased in a dose-dependent manner with oleic acid treatment at various concentrations (n = 8). (E) Lung morphology, characterized by hypersecretion of mucus, proliferation of epithelial cells, and infiltration of inflammatory cells around the bronchoalveolar ducts and blood vessels, which were altered due to OVA, improved with oleic acid treatment in a dose-dependent manner. Scale bar, 100 μm; magnification, × 200. (F) Bronchoalveolar mucus secretion induced by OVA was reduced by treatment with varying concentrations of oleic acid (in a dose-dependent manner). Scale bar, 100 μm; magnification, × 200. a, CON; b, OVA; c, 1 mg/kg DEX; d, 50 mg/kg oleic acid; e, 125 mg/kg oleic acid; f, 250 mg/kg oleic acid. The results are expressed as the mean ± standard deviation. * p < 0.05 vs. CON; ** p < 0.001 vs. CON; $ p < 0.05 vs. OVA; $$ p < 0.001 vs. OVA; # p < 0.05 vs. 1 mg/kg DEX; ## p < 0.001 vs. 1 mg/kg DEX; @ p < 0.05 vs. 50 mg/kg oleic acid; @@ p < 0.001 vs. 50 mg/kg oleic acid; & p < 0.05 vs. 125 mg/kg oleic acid.

    Article Snippet: Differential cell counts were performed on the resuspended BALF white blood cells (WBCs) using a Hemavet Multispecies Hematology System (Drew Scientific, Waterbury, CT, USA) and the Diff Quik staining set (Thermo Fisher Scientific).

    Techniques: Concentration Assay, Diff-Quik, Staining, Standard Deviation